» Articles » PMID: 31008184

Enhanced Activation and Expansion of T Cells Using Mechanically Soft Elastomer Fibers

Overview
Journal Adv Biosyst
Date 2019 Apr 23
PMID 31008184
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Practical deployment of cellular therapies requires effective platforms for producing clinically relevant numbers of high-quality cells. This report introduces a materials-based approach to improving activation and expansion of T cells, which are rapidly emerging as an agent for treating cancer and a range of other diseases. Electrospinning is used to create a mesh of poly(ε-caprolactone) fibers, which is used to present activating ligands to CD3 and CD28, which activate T cells for expansion. Incorporation of poly(dimethyl siloxane) elastomer into the fibers reduces substrate rigidity and enhances expansion of mixed populations of human CD4 and CD8 T cells. Intriguingly, this platform also rescues expansion of T cells isolated from CLL patients, which often show limited responsiveness and other features resembling exhaustion. By simplifying the process of cell expansion, compared to current bead-based platforms, and improving T cell expansion, the system introduced here may accelerate development of cellular immunotherapy.

Citing Articles

Taming Variability in T-Cell Mechanosensing.

Schultheiss P, Pulkundwar A, Li W, Kam L Cells. 2025; 14(3).

PMID: 39936994 PMC: 11817355. DOI: 10.3390/cells14030203.


Assaying and classifying T cell function by cell morphology.

Wang X, Fernandes S, Brown J, Kam L BioMedInformatics. 2024; 4(2):1144-1154.

PMID: 39525274 PMC: 11542667. DOI: 10.3390/biomedinformatics4020063.


encapsulation and expansion of T and CAR-T cells using 3D synthetic thermo-responsive matrices.

Lizana-Vasquez G, Mendez-Vega J, Cappabianca D, Saha K, Torres-Lugo M RSC Adv. 2024; 14(20):13734-13747.

PMID: 38681842 PMC: 11046447. DOI: 10.1039/d4ra01968g.


Electrospun nanofibrous mats loaded with gemcitabine and cisplatin suppress bladder tumor growth by improving the tumor immune microenvironment.

Wang J, Yin Y, Ren X, Wang S, Zhu Y J Mater Sci Mater Med. 2024; 35(1):21.

PMID: 38526656 PMC: 10963565. DOI: 10.1007/s10856-024-06786-y.


Preclinical models for development of immune-oncology therapies.

Wang Y, Shelton S, Kastrunes G, Barbie D, Freeman G, Marasco W Immuno-oncol Insights. 2023; 3(8):379-398.

PMID: 37132013 PMC: 10150782. DOI: 10.18609/ioi.2022.41.


References
1.
Riches J, Davies J, McClanahan F, Fatah R, Iqbal S, Agrawal S . T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood. 2012; 121(9):1612-21. PMC: 3587324. DOI: 10.1182/blood-2012-09-457531. View

2.
Restifo N, Dudley M, Rosenberg S . Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012; 12(4):269-81. PMC: 6292222. DOI: 10.1038/nri3191. View

3.
Brentjens R, Riviere I, Park J, Davila M, Wang X, Stefanski J . Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood. 2011; 118(18):4817-28. PMC: 3208293. DOI: 10.1182/blood-2011-04-348540. View

4.
Zajac A, Blattman J, Sourdive D, Suresh M, Altman J, Ahmed R . Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998; 188(12):2205-13. PMC: 2212420. DOI: 10.1084/jem.188.12.2205. View

5.
Lambert L, Goebrecht G, De Leo S, OConnor R, Nunez-Cruz S, Li T . Improving T Cell Expansion with a Soft Touch. Nano Lett. 2017; 17(2):821-826. PMC: 5504474. DOI: 10.1021/acs.nanolett.6b04071. View